Impact of FOLFIRINOX compared with gemcitabine on quality of life in patients with metastatic pancreatic cancer: results from the PRODIGE 4/ACCORD 11 randomized trial (Q34646032)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Impact of FOLFIRINOX compared with gemcitabine on quality of life in patients with metastatic pancreatic cancer: results from the PRODIGE 4/ACCORD 11 randomized trial |
scientific article |
Statements
1 reference
Impact of FOLFIRINOX compared with gemcitabine on quality of life in patients with metastatic pancreatic cancer: results from the PRODIGE 4/ACCORD 11 randomized trial (English)
1 reference
Caroline Bascoul-Mollevi
1 reference
Rosine Guimbaud
1 reference
Sophie Gourgou-Bourgade
1 reference
Françoise Desseigne
1 reference
Olivier Bouché
1 reference
Yves Bécouarn
1 reference
Antoine Adenis
1 reference
Jean-Luc Raoul
1 reference
Jocelyne Bérille
1 reference
Thierry Conroy
1 reference
3 December 2012
1 reference
1 reference
Identifiers
1 reference